Eurocine Vaccines is a pharmaceutical company. The company develops vaccines using its proprietary technology platform Endocine™, which vaccines are subsequently licensed to partners for further development and commercialization. Development is carried out in cooperation with other companies in the industry. The technology platform Endocine™ is also offered to other companies for development within certain indications. The head office is located in Solna.

Quotes for Eurocine Vaccines AB

Right Now

+/-
-0.145
%
-3,56%
Latest
3.93
High
4.015
Low
3.83
Volume
27 497
Turnover (SEK)
107 781
Value (MSEK)
31,0

Board

CEO

  • Hans Arwidsson

Chairman Of The Board

  • Pierre Morgon

Board

  • Emanuele Montomoli
  • Hans Arwidsson
  • Jan Sandström
  • Pär Thuresson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 5,48 5,48 2021-03-31
Nordnet Pensionsförsäkring 3,20 3,20 2021-03-31
Jan Kennet Karjalainen 2,39 2,39 2021-03-31
VisMederi Srl 1,73 1,73 2021-03-31
BRL Invest AB 1,59 1,59 2021-03-31
Niclas Falk 1,14 1,14 2021-03-31
Göran Erlandsson 1,13 1,13 2021-03-31
Kent Olsson 1,12 1,12 2021-03-31
Ari Korpela 0,84 0,84 2021-03-31
Bo Sjögren 0,79 0,79 2021-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream